694. Characterization of the Mechanisms of Tumor Dormancy and Recurrence Following Front Line Immuno-, Viro- Or Suicide Gene-, Therapy

Molecular Therapy - United States
doi 10.1016/s1525-0016(16)36498-x
Full Text
Abstract

Available in full text

Date
Authors

Unknown

Publisher

Elsevier BV

Related search

Tumor Dormancy: Potential Therapeutic Target in Tumor Recurrence and Metastasis Prevention

Experimental Hematology and Oncology
Cancer ResearchOncologyHematology
2013English

Tumor Cell Escape From Therapy-Induced Senescence as a Model of Disease Recurrence After Dormancy

Cancer Research
Cancer ResearchOncology
2019English

Oncolytic Plasmid: A Novel Strategy for Tumor Immuno-Gene Therapy

Oncology Letters
Cancer ResearchOncology
2011English

Cloning and Characterization of a Retroviral Plasmid, pCC1, for Combination Suicide Gene Therapy

BioTechniques
BiochemistryBiotechnologyGeneticsMolecular Biology
2000English

Enhanced Suicide Gene Therapy Using a Tumor-Specific Promoter in Combination With Cisplatin

Molecular Medicine Reports
OncologyGeneticsMolecular BiologyBiochemistryCancer ResearchMolecular Medicine
2009English

Vector-Producing Tumor-Tracking Multipotent Mesenchymal Stromal Cells for Suicide Cancer Gene Therapy

Frontiers in Bioscience - Landmark
ImmunologyMolecular BiologyBiochemistryMicrobiology MedicineGenetics
2008English

Tumor Cell Dormancy: Threat or Opportunity in the Fight Against Cancer

Cancers
Cancer ResearchOncology
2019English

Advancement and Prospects of Tumor Gene Therapy

Chinese Journal of Cancer
2011English

Efficacy of Bevacizumab Therapy in Recurrent Malignant Gliomas in Relation to the Prior Recurrence Pattern or Tumor Location

Journal of Clinical Neuroscience
MedicineSurgeryNeurologyPhysiology
2017English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy